ATE195072T1 - Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen - Google Patents
Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungenInfo
- Publication number
- ATE195072T1 ATE195072T1 AT96102860T AT96102860T ATE195072T1 AT E195072 T1 ATE195072 T1 AT E195072T1 AT 96102860 T AT96102860 T AT 96102860T AT 96102860 T AT96102860 T AT 96102860T AT E195072 T1 ATE195072 T1 AT E195072T1
- Authority
- AT
- Austria
- Prior art keywords
- aminotetralines
- substituted
- treatment
- antipyretic
- septic shock
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000143A IT1278045B1 (it) | 1995-03-09 | 1995-03-09 | Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE195072T1 true ATE195072T1 (de) | 2000-08-15 |
Family
ID=11403118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96102860T ATE195072T1 (de) | 1995-03-09 | 1996-02-26 | Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen |
Country Status (14)
Country | Link |
---|---|
US (1) | US5591777A (de) |
EP (1) | EP0730861B1 (de) |
JP (1) | JPH08268884A (de) |
KR (1) | KR100286141B1 (de) |
AT (1) | ATE195072T1 (de) |
CA (1) | CA2171081A1 (de) |
DE (1) | DE69609541T2 (de) |
DK (1) | DK0730861T3 (de) |
ES (1) | ES2150034T3 (de) |
GR (1) | GR3034688T3 (de) |
IT (1) | IT1278045B1 (de) |
PT (1) | PT730861E (de) |
TW (1) | TW471967B (de) |
ZA (1) | ZA961897B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1290910B1 (it) * | 1997-02-03 | 1998-12-14 | Sigma Tau Ind Farmaceuti | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive |
IT1294932B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie |
IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
US7125904B2 (en) | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1199339B (it) * | 1986-12-23 | 1988-12-30 | Sigma Tau Ind Farmaceuti | N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono |
SE8904127D0 (sv) * | 1989-12-07 | 1989-12-07 | Astra Ab | New biocyclic amino-substituted compounds |
IT1241988B (it) * | 1990-06-15 | 1994-02-02 | Sigma Tau Ind Farmaceuti | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono |
-
1995
- 1995-03-09 IT IT95RM000143A patent/IT1278045B1/it active IP Right Grant
-
1996
- 1996-02-26 EP EP96102860A patent/EP0730861B1/de not_active Expired - Lifetime
- 1996-02-26 AT AT96102860T patent/ATE195072T1/de not_active IP Right Cessation
- 1996-02-26 ES ES96102860T patent/ES2150034T3/es not_active Expired - Lifetime
- 1996-02-26 PT PT96102860T patent/PT730861E/pt unknown
- 1996-02-26 DE DE69609541T patent/DE69609541T2/de not_active Expired - Fee Related
- 1996-02-26 DK DK96102860T patent/DK0730861T3/da active
- 1996-02-27 US US08/607,452 patent/US5591777A/en not_active Expired - Fee Related
- 1996-02-29 TW TW085102443A patent/TW471967B/zh not_active IP Right Cessation
- 1996-03-05 CA CA002171081A patent/CA2171081A1/en not_active Abandoned
- 1996-03-07 KR KR1019960005965A patent/KR100286141B1/ko not_active IP Right Cessation
- 1996-03-08 ZA ZA961897A patent/ZA961897B/xx unknown
- 1996-03-11 JP JP8053075A patent/JPH08268884A/ja active Pending
-
2000
- 2000-10-26 GR GR20000402375T patent/GR3034688T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3034688T3 (en) | 2001-01-31 |
DE69609541T2 (de) | 2000-12-21 |
TW471967B (en) | 2002-01-11 |
PT730861E (pt) | 2000-11-30 |
KR100286141B1 (ko) | 2001-04-16 |
ZA961897B (en) | 1996-09-12 |
CA2171081A1 (en) | 1996-09-10 |
EP0730861B1 (de) | 2000-08-02 |
JPH08268884A (ja) | 1996-10-15 |
KR960033450A (ko) | 1996-10-22 |
ES2150034T3 (es) | 2000-11-16 |
US5591777A (en) | 1997-01-07 |
EP0730861A1 (de) | 1996-09-11 |
ITRM950143A0 (it) | 1995-03-09 |
IT1278045B1 (it) | 1997-11-17 |
DK0730861T3 (da) | 2000-10-09 |
ITRM950143A1 (it) | 1996-09-09 |
DE69609541D1 (de) | 2000-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
ATE50763T1 (de) | Tetralin-derivate, ihre herstellung und verwendung. | |
DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
ATE202706T1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
ATE262336T1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
DE69913665D1 (de) | Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten | |
NO890259L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
DE69106586D1 (de) | Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris. | |
DE69333931D1 (de) | Verwendung von Krillenzymen zur Behandlung von Zahnbelag | |
DE69124769D1 (de) | Verfahren zur Herstellung von (1'R,3S)-3-(1'-hydroxy-ethyl)-Azetidin-2-on und deren Derivaten | |
FR2670669B1 (fr) | Instrument de correction chirurgicale de l'astigmatisme. | |
DE69424009D1 (de) | Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst | |
ATE79031T1 (de) | Verwendung von ketonderivaten zur behandlung von depressionen. | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
ATE53377T1 (de) | 1-substituierte tetralinderivate, ihre herstellung und verwendung. | |
DE69805305D1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
DE69400342D1 (de) | Verfahren zur Herstellung von 1,1,1,2-Tetrafluor-2-Chlorethan und Pentafluorethan | |
ATE39694T1 (de) | (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung. | |
ATE92469T1 (de) | Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung. | |
DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
ATE195072T1 (de) | Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen | |
ATE151774T1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen | |
ATE83480T1 (de) | Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. | |
ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |